GlobeNewswire: Fuisz Pharma LLC Contains the last 10 of 12 releaseshttp://www.globenewswire.com/External?Length=42024-03-28T13:58:47ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2020/04/06/2011990/0/en/Bond-Street-Manufacturing-LLC-Received-Notice-of-Allowance-from-the-US-Patent-Office-for-its-Heat-Not-Burn-Compositions.html?f=22&fvtc=4&fvtv=24673Bond Street Manufacturing LLC Received Notice of Allowance from the US Patent Office for its Heat Not Burn Compositions2020-04-06T11:00:00Z<![CDATA[Williamson County, TN, April 06, 2020 (GLOBE NEWSWIRE) -- Bond Street Manufacturing LLC (Bond Street), an affiliate of Fuisz LLC, has announced receipt of a notice of allowance from the US Patent Office (US 15/276,902). The patent allowance relates to Bond Street’s heat-not-burn Tobacco Wax compositions.]]>Bond Street Device Bond Street DeviceComparative Data Bond Street Datahttps://www.globenewswire.com/news-release/2018/11/09/1648905/0/en/Fuisz-Pharma-LLC-Announces-Notice-of-Patent-Allowance-for-its-System-of-Custody-and-Control-for-Abusable-Drugs-Blockchain-like-HIPPA-Compliant-Technology-Applies-Custody-and-Contro.html?f=22&fvtc=4&fvtv=24673Fuisz Pharma LLC Announces Notice of Patent Allowance for its System of Custody and Control for Abusable Drugs: Blockchain like HIPPA Compliant Technology Applies Custody and Control Parameters to Unit Dose Packaged Drugs2018-11-09T12:45:00Z<![CDATA[Miami, FL, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today that it has received a Notice of Allowance from the United States Patent Office in connection with its patent application (Serial No. 15/905,396) entitled, “Package, System and Methods for Custody and Control of Drugs, and Method and Composition for Making an Oral Soluble Film, containing at least one active agent.”]]>https://www.globenewswire.com/news-release/2018/10/08/1617881/0/en/Fuisz-Pharma-LLC-Announces-Allowance-of-Additional-Patent-Claims-for-its-New-Film-by-Deposit-Technology-Platform.html?f=22&fvtc=4&fvtv=24673Fuisz Pharma LLC Announces Allowance of Additional Patent Claims for its New Film by Deposit Technology Platform2018-10-08T11:45:00Z<![CDATA[Miami, FL, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC (Fuisz) announced today the allowance of additional patent claims for its Film by Deposit Technology Platform.]]>https://www.globenewswire.com/news-release/2018/03/05/1415116/0/en/Update-Fuisz-Pharma-Announces-Issuance-of-Oral-Thin-Film-Pharmaceutical-Patent-re-release.html?f=22&fvtc=4&fvtv=24673Update: Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent (re-release)2018-03-05T15:30:00Z<![CDATA[Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film pharmaceuticals. The ‘545 Patent is entitled: “Method and composition for making an oral soluble film, containing at least one active agent.”]]>https://www.globenewswire.com/news-release/2018/03/05/1414777/0/en/Fuisz-Pharma-Announces-Issuance-of-Oral-Thin-Film-Pharmaceutical-Patent.html?f=22&fvtc=4&fvtv=24673Fuisz Pharma Announces Issuance of Oral Thin Film Pharmaceutical Patent2018-03-05T12:30:00Z<![CDATA[Miami, FL, March 05, 2018 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today the issuance of a new patent, US 9,901,545 (the “’545 Patent”) concerning the manufacture of oral thin film pharmaceuticals. The ‘545 Patent is entitled: “Method and composition for making an oral soluble film, containing at least one active agent.”]]>https://www.globenewswire.com/news-release/2017/11/09/1178474/0/en/FUISZ-LLC-Announces-Availability-of-Critical-Database-Patent-Family-for-Licensing-or-Enforcement-Use.html?f=22&fvtc=4&fvtv=24673FUISZ LLC Announces Availability of Critical Database Patent Family for Licensing or Enforcement Use2017-11-09T12:00:00Z<![CDATA[Miami, FL, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Fuisz LLC (www.fuisz.com) today announced the availability of a critical, early patent family relating to e-commerce database methods and systems.]]>https://www.globenewswire.com/news-release/2017/06/05/1008062/0/en/Fuisz-Announces-Allowance-for-Keystone-Patent-in-the-Field-of-Breath-based-Medical-Diagnostics.html?f=22&fvtc=4&fvtv=24673Fuisz Announces Allowance for Keystone Patent in the Field of Breath-based Medical Diagnostics2017-06-05T11:30:00Z<![CDATA[Bethlehem, PA, June 05, 2017 (GLOBE NEWSWIRE) -- Fuisz Pharma LLC announced today that it has received a notice of allowance for the patent application titled “Method and System to Amplify and Measure Breath Analytes” (Appl. No. 13/423,527).]]>https://www.globenewswire.com/news-release/2017/04/17/961283/0/en/FUISZ-Announces-Filing-of-Patent-Application-Relating-to-New-Manufacturing-Methods-and-Compositions-for-Oral-Soluble-Films-Superior-to-Wet-Casting-Methodologies-Amended-Press-Relea.html?f=22&fvtc=4&fvtv=24673FUISZ Announces Filing of Patent Application Relating to New Manufacturing Methods and Compositions for Oral Soluble Films, Superior to Wet Casting Methodologies (Amended Press Release)2017-04-17T12:45:00Z<![CDATA[Bethlehem, PA, April 17, 2017 (GLOBE NEWSWIRE) -- Fuisz today announced the filing of a patent application with the United States Patent & Trademark Office relating to new methods of manufacture for, and new compositions of oral soluble films. Fuisz principals Richard Fuisz and Joseph Fuisz are long active in oral drug delivery systems. Richard Fuisz was the primary inventor of the Fuisz Technologies’ shearform matrix quick dissolve tablet (e.g. US 4,855,326). Richard and Joseph became inventors on the largest wet cast thin film drug delivery patent estate, which has been successfully employed to protect Suboxone® thin film from generic entrants (e.g. US 7,824,588). They also developed and patented a novel method of achieving sustained drug release in extruded sheets (US 8,613,285), which was acquired by a global consumer products company. They patented new ways of delivering botanical actives by hot melt extrusion (US 9,125,434). And they developed a method of making monolayer films with bilayer functionality (US 8,617,589) acquired by a leading oral thin film company.]]>https://www.globenewswire.com/news-release/2017/04/17/961243/0/en/FUISZ-Announces-Filing-of-Patent-Application-Relating-to-New-Manufacturing-Methods-and-Compositions-for-Oral-Soluble-Films-Superior-to-Wet-Casting-Methodologies.html?f=22&fvtc=4&fvtv=24673FUISZ Announces Filing of Patent Application Relating to New Manufacturing Methods and Compositions for Oral Soluble Films, Superior to Wet Casting Methodologies2017-04-17T11:30:00Z<![CDATA[Bethlehem, PA, April 17, 2017 (GLOBE NEWSWIRE) -- Fuisz today announced the filing of a patent application with the United States Patent & Trademark Office relating to new methods of manufacture for, and new compositions of oral soluble films. Fuisz principals Richard Fuisz and Joseph Fuisz are long active in oral drug delivery systems. Richard Fuisz was the primary inventor of the Fuisz Technologies’ shearform matrix quick dissolve tablet (e.g. US 4,855,326). Richard and Joseph became inventors on the largest wet cast thin film drug delivery patent estate, which has been successfully employed to protect Suboxone® thin film from generic entrants (e.g. US 7,824,588). They also developed and patented a novel method of achieving sustained drug release in extruded sheets (US 8,613,285), which was acquired by a global consumer products company. They patented new ways of delivering botanical actives by hot melt extrusion (US 9,125,434). And they developed a method of making monolayer films with bilayer functionality (US 8,617,589) acquired by a leading oral thin film company.]]>https://www.globenewswire.com/news-release/2016/04/11/827547/0/en/FUISZ-Announces-Smart-Telephony-Patent-Issuance-Invention-Enables-Voice-Call-Prioritization-so-Smart-Phones-can-Function-Smartly.html?f=22&fvtc=4&fvtv=24673FUISZ Announces Smart Telephony Patent Issuance; Invention Enables Voice Call Prioritization so Smart Phones can Function Smartly2016-04-11T12:00:00Z<![CDATA[Miami, Florida, April 11, 2016 (GLOBE NEWSWIRE) -- Fuisz today announced the issuance of United States Patent 9,288,649 (“Smart telephony systems and methods”). This patented system allows a phone caller to alert the recipient of the call’s priority. Additional features allow a priority caller to force a silent phone to audibly ring, turn “on” a phone that is “off”, and the integration of priority calls with medical devices.]]>